Elyxium Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Sell
1,254
-56
-4% -$15.5K 0.03% 235
2026
Q1
$387K Sell
1,310
-80
-6% -$23.8K 0.12% 113
2025
Q4
$380K Sell
1,390
-60
-4% -$16.3K 0.11% 124
2025
Q3
$392K Sell
1,450
-243
-14% -$66.1K 0.14% 114
2025
Q2
$467K Buy
1,693
+329
+24% +$89.5K 0.18% 102
2025
Q1
$362K Buy
+1,364
New +$336K 0.16% 105
2024
Q4
– Sell
-1,050
Closed -$232K – 98
2024
Q3
$232K Buy
+1,050
New +$217K 0.13% 112

Other funds holding CME

Elyxium Wealth's CME Position: Q2 2026 in Review

Elyxium Wealth reduced its CME Group (CME) stake by 4.3% in Q2 2026, selling an estimated $15.5K and leaving 1,254 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #235.

Elyxium Wealth first reported a position in CME in Q3 2024 and has held it in 7 quarters since. The position peaked at $467K in Q2 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Elyxium Wealth held 1,254 shares of CME Group worth $277K as of Q2 2026.
  • Elyxium Wealth sold 56 CME Group shares in Q2 2026, an estimated $15.5K.
  • CME Group made up 0.03% of Elyxium Wealth's portfolio in Q2 2026, its #235 holding.
  • Elyxium Wealth first reported a position in CME Group in Q3 2024 and has held it in 7 quarters since.
  • Elyxium Wealth's CME Group position peaked at $467K in Q2 2025.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.